Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
- PMID: 33312320
- PMCID: PMC7721595
- DOI: 10.1016/j.radcr.2020.11.029
Pulmonary and intracranial miliary tuberculosis secondary to Behçet's anti-TNF alfa treatment
Abstract
Behçet disease is a rare vasculitis that affects vessels of different body parts, causing different kinds of manifestations. We report a case of a 47 years old woman who had a tumor necrosis factor alfa blocker prescription due to a Behçet's disease relapse. The patient then developed a cerebral and pulmonary tuberculous miliary due to immunodeficiency. The aim of this work is to show that tuberculosis infection is a common complication of the administration of tumor necrosis factor alfa blocker, and the importance to perform a tuberculosis screening before starting the treatment.
Keywords: Anti-TNF alfa; Behçet's disease; Immunodeficiency; Miliary; Tuberculosis.
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
Figures



References
-
- Kone-Paut I, Barete S, Bodaghi B, Deiva K, Desbois A-C, Galeotti C, et al. Protocole National de Diagnostic et de Soins sur la Maladie de Behçet. Les « recommandations de bonne pratique ». HAS - Haute Autorité de Santé. 2020
-
- Alami B, Boujraf S, Quenum L, Alaoui Lamrani MY, Haloua M, Boubbou M. Cerebral venous thrombosis: clinical and radiological features, about 62 cases. J Med Vasc. 2019;44:387–399. - PubMed
-
- Zuber J-P, Bart P-A, Leimgruber A, Spertini F. Maladie de Behçet: d'Hippocrate aux antagonites du TNF-alpha. Revue médicale suisse. 2008;4:1045–1054. - PubMed
-
- Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098–1104. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources